1
/
of
0
FDA Decision Memorandum on Semaglutide Shortage Resolution – February 21, 2025
FDA Decision Memorandum on Semaglutide Shortage Resolution – February 21, 2025
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: Please provide us with the redacted version of FDA's February 21, 2025 decision memorandum regarding the decision to designate the shortage of Novo Nordisk’s Semaglutide drug as resolved.
Tags: Pharma, Recall, 2025
Tags: Pharma, Recall, 2025
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details